Community
Advertising Opportunities
Biotechnology Europe Programs
Biotechnology Europe Community
Feedback
Contact
Biotechnology Europe Advantages
Advertising Opportunities on Biotechnology Europe
Sponsorship Opportunities on Biotechnology Europe
Post a Job on Biotechnology Europe
Post a Company Profile on Biotechnology Europe
Post a News on Biotechnology Europe
Post an Event on Biotechnology Europe
Post a Product on Biotechnology Europe
Post a Publication on Biotechnology Europe
Post a Technology on Biotechnology Europe
Post a Resume on Biotechnology Europe
Terms of Business
Imprint
Privacy Policy
FAQ
Subscribe Newsletter
BIOTECHNOLOGY EUROPE-NORTH AMERICA
post your news I subscribe newsletter I contact us
23.10.2008 Amgen's Third Quarter 2008 Adjusted Earnings Per Share Increased 14 Percent to $1.23
22.10.2008 Cell Therapeutics, Inc. Announces Single Institutional Investor Purchases $24.7 Million of Senior Convertible Notes
20.10.2008 Amgen Announces Webcast of 2008 Third Quarter Financial Results
20.10.2008 BIO Ventures for Global Health to Work with Industry to Educate, Promote PRV Program
20.10.2008 High-Dose Zevalin(R) With Tandem Stem Cell Infusion Produces 87 Percent Overall Survival in Relapsed/Refractory or High Risk Non-Hodgkin's Lymphoma
20.10.2008 Genentech Announces Phase III Study of Avastin Plus Chemotherapy in Adjuvant Colon Cancer Will Continue
14.10.2008 Genentech Announces Third Quarter 2008 Results
14.10.2008 BIO VENTURES for Global Health Receives $7 Million Grant from Gates Foundation to Engage Biotechnology in the Fight Against Neglected Diseases of the Developing World
07.10.2008 Phase III Study Showed Rituxan in Combination with Chemotherapy Improved Progression-Free Survival in Patients with Relapsed Chronic Lymphocytic Leukemia
06.10.2008 Genentech and OSI Pharmaceuticals Announce Topline Results from Phase III Study Evaluating the Combination of Avastin and Tarceva as Second-Line Treatment for Advanced Non-Small Cell Lung Cancer
03.10.2008 Amgen Appoints Francois de Carbonnel to the Company's Board of Directors
03.10.2008 Genentech, Glycart and Roche Enter Into Collaboration Agreement for Potential Cancer Therapy
02.10.2008 Genentech Issues Dear Healthcare Provider Letter Regarding a Reported Case of PML in a Raptiva Patient
02.10.2008 District Court Affirms Patent Infringement Rulings and Finds That Amgen is Entitled to a Permanent Injunction against Roche
02.10.2008 Cell Therapeutics Submits Supplemental Biologics License Application for Zevalin Use in First-Line Consolidation Therapy
office@biotechnology-europe.com I website@biotechnology-europe.com I service@biotechnology-europe.com
About Biotechnology Europe
